These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22019516)

  • 1. In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate.
    Chuang CH; Chuang KH; Wang HE; Roffler SR; Shiea JT; Tzou SC; Cheng TC; Kao CH; Wu SY; Tseng WL; Cheng CM; Hou MF; Wang JM; Cheng TL
    Clin Cancer Res; 2012 Jan; 18(1):238-47. PubMed ID: 22019516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
    Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
    J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
    Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
    Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
    van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
    Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells.
    Zhao T; Harada H; Teramura Y; Tanaka S; Itasaka S; Morinibu A; Shinomiya K; Zhu Y; Hanaoka H; Iwata H; Saji H; Hiraoka M
    J Control Release; 2010 May; 144(1):109-14. PubMed ID: 20096316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular imaging for PET-CT reporter gene in breast adenocarcinoma (HSV1-tk) of subcutaneous xenografts in living nude mice].
    Xu WG; Dai D; Fang N; Song XY; Wang J; Zhu YJ; Men XY
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(48):3420-4. PubMed ID: 20223118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors.
    Eder M; Pavan S; Bauder-Wüst U; van Rietschoten K; Baranski AC; Harrison H; Campbell S; Stace CL; Walker EH; Chen L; Bennett G; Mudd G; Schierbaum U; Leotta K; Haberkorn U; Kopka K; Teufel DP
    Cancer Res; 2019 Feb; 79(4):841-852. PubMed ID: 30606721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-PET imaging of beta-glucuronidase activity by the hydrophobic conversion of a glucuronide probe.
    Tzou SC; Roffler S; Chuang KH; Yeh HP; Kao CH; Su YC; Cheng CM; Tseng WL; Shiea J; Harm IH; Cheng KW; Chen BM; Hwang JJ; Cheng TL; Wang HE
    Radiology; 2009 Sep; 252(3):754-62. PubMed ID: 19717754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).
    Wängler C; Waser B; Alke A; Iovkova L; Buchholz HG; Niedermoser S; Jurkschat K; Fottner C; Bartenstein P; Schirrmacher R; Reubi JC; Wester HJ; Wängler B
    Bioconjug Chem; 2010 Dec; 21(12):2289-96. PubMed ID: 21082773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers.
    Kondo N; Temma T; Shimizu Y; Ono M; Saji H
    Biol Pharm Bull; 2015; 38(9):1375-82. PubMed ID: 26328493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging.
    Jastrzebska B; Lebel R; Therriault H; McIntyre JO; Escher E; Guérin B; Paquette B; Neugebauer WA; Lepage M
    J Med Chem; 2009 Mar; 52(6):1576-81. PubMed ID: 19228016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel matrix metalloproteinase inhibitor [18F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer.
    auf dem Keller U; Bellac CL; Li Y; Lou Y; Lange PF; Ting R; Harwig C; Kappelhoff R; Dedhar S; Adam MJ; Ruth TJ; Bénard F; Perrin DM; Overall CM
    Cancer Res; 2010 Oct; 70(19):7562-9. PubMed ID: 20729277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models.
    Kasten BB; Jiang K; Cole D; Jani A; Udayakumar N; Gillespie GY; Lu G; Dai T; Rosenthal EL; Markert JM; Rao J; Warram JM
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1412-1426. PubMed ID: 31773232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.
    Collingridge DR; Carroll VA; Glaser M; Aboagye EO; Osman S; Hutchinson OC; Barthel H; Luthra SK; Brady F; Bicknell R; Price P; Harris AL
    Cancer Res; 2002 Oct; 62(20):5912-9. PubMed ID: 12384557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.